Invitation to full year 2017 presentation

Posted on Mar 13, 2018

Oslo, 13 March 2018 – PCI Biotech invites to a presentation of the company’s full year 2017 report on Tuesday 20 March 2018 at Oslo Cancer Cluster Innovation Park. Time: Tuesday March 20, 08:30am – 09:30am CET (local time). Venue: Jónas Einarsson aud. (2nd floor, entrance 2B), Oslo Cancer Cluster Innovation Park, Ullernchausséen 64, Oslo […]

PCI Biotech to present at Bio-Europe Spring 2018

Posted on Mar 12, 2018

Oslo, Norway, March 12, 2018 – PCI Biotech (OSE:PCIB), a clinical-stage company developing innovative therapeutics that address significant unmet medical needs, today announced that it will present at Bio-Europe Spring 2018 being held March 12-14, 2018 at the Amsterdam RAI Convention Center, Amsterdam, The Netherlands. On Wednesday, March 14, 2018 at 10:15am (CET), Mr. Gaël L’Hévéder, […]

Extension of preclinical research collaboration agreement with a top-10 large pharma company

Posted on Jan 18, 2018

Oslo (Norway), 18 January 2018 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company today announced that they are extending the preclinical research collaboration with an undisclosed top-10 pharma company, initiated in September 2015. The extended evaluation period spans over 6 months, until the end of June 2018, and may be further extended. The […]